Prusogliptin/Metformin

普卢格列汀/二甲双胍

Report date: 2026/01/09 09:46:49

Base Information

Drug NamePrusogliptin/Metformin
Drug Alias Name普卢格列汀二甲双胍缓释片
ClassificationSmall molecules
Mechanisms of ActionDipeptidyl peptidase IV inhibitorsProtein kinase AMP-activated non-catalytic subunit beta 1 activators
TargetsDipeptidyl peptidase IVProtein kinase AMP-activated non-catalytic subunit beta 1
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes PrusogliptinMetformin Hydrochloride
Global Highest StatusNDA/BLA
Highest Status in ChinaNDA/BLA
Originator CompaniesCspc Ouyi Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCspc Ouyi Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A